ARTRYA Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.122x

ARTRYA Ltd cash flow conversion efficiency. Based on the latest financial reports, ARTRYA Ltd (AYA) has a cash flow conversion efficiency ratio of -0.122x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-10.88 Million ≈ $-7.70 Million USD) by net assets (AU$89.35 Million ≈ $63.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of ARTRYA Ltd (2019–2025)

Cash flow conversion efficiency of ARTRYA Ltd from 2019 to 2025. This chart illustrates how ARTRYA Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View AYA stock price and chart for real-time trading data and today's change.

ARTRYA Ltd Cash Flow Conversion Ratio Explained

ARTRYA Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

ARTRYA Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ARTRYA Ltd ranked by their cash flow conversion efficiency. Also see AYA market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Beijing Sanfo Outdoor Products Co Ltd
SHE:002780
-0.026x
Camping World Holdings Inc
NYSE:CWH
0.290x
Marcopolo S.A
SA:POMO3
0.205x
Altshuler Shaham Financial LTD
TA:ALTF
0.027x
Rongfeng Holding Group
SHE:000668
-0.065x
Chengdu Dahongli Machinery Co Ltd
SHE:300865
0.015x
Unggul Indah Cahaya Tbk
JK:UNIC
0.088x
Beijing InHand Networks Technology Co Ltd
SHG:688080
0.071x

Annual Cash Flow Conversion Efficiency for ARTRYA Ltd (2019–2025)

The table below shows the annual cash flow conversion efficiency of ARTRYA Ltd from 2019 to 2025. Review financial agility of ARTRYA Ltd to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$21.29 Million
≈ $15.06 Million
AU$-14.27 Million
≈ $-10.10 Million
-0.670x +26.89%
2024-06-30 AU$16.80 Million
≈ $11.89 Million
AU$-15.41 Million
≈ $-10.90 Million
-0.917x -160.90%
2023-06-30 AU$30.56 Million
≈ $21.62 Million
AU$-10.74 Million
≈ $-7.60 Million
-0.351x -48.68%
2022-06-30 AU$40.64 Million
≈ $28.76 Million
AU$-9.61 Million
≈ $-6.80 Million
-0.236x -711.62%
2021-06-30 AU$51.05 Million
≈ $36.12 Million
AU$-1.49 Million
≈ $-1.05 Million
-0.029x +95.53%
2020-06-30 AU$2.49 Million
≈ $1.76 Million
AU$-1.62 Million
≈ $-1.15 Million
-0.651x -478.82%
2019-06-30 AU$852.97K
≈ $603.53K
AU$-95.94K
≈ $-67.89K
-0.112x --

About ARTRYA Ltd

AU:AYA Australia Health Information Services
Market Cap
$313.99 Million
AU$443.76 Million AUD
Market Cap Rank
#14293 Global
#378 in Australia
Share Price
AU$2.77
Change (1 day)
+1.47%
52-Week Range
AU$2.45 - AU$6.27
All Time High
AU$6.27
About

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography sca… Read more